세계 심장 절제 시장 : 규모 및 예측 - 제품별, 기술별, 용도별, 최종 용도별, 지역별 분석(2023년-2030년)

Global Cardiac Ablation Market is valued at approximately USD 3.8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.2% over the forecast period 2023-2030. Cardiac ablation refers to a medical procedure used to treat certain heart rhythm disorders by selectively destroying abnormal tissue in the heart using energy-based techniques. The Cardiac Ablation Market is expanding because of factors such as the growing aging population and increasing prevalence of cardiovascular diseases. Furthermore, the rising incidence of cardiovascular diseases, such as arrhythmias and atrial fibrillation, is increasing the demand for cardiac ablation procedures.

The rapid rise in geriatric people is directly fueling the market demand across the globe. According to the World Health Organization, the proportion of individuals aged 60 years or older in the world is projected to reach 1 in 6 by 2030. During this time, the population of people aged 60 years and over is expected to increase from 1 billion in 2020 to 1.4 billion. Furthermore, by 2050, the global population of individuals aged 60 years and older is anticipated to double, reaching 2.1 billion. Accordingly, the number of individuals aged 80 years or older is predicted to triple between 2020 and 2050, reaching a total of 426 million. In addition, Technological advancements in cardiac ablation and the introduction of advanced robotic technologies would create lucrative growth opportunities. However, stringent regulations and high investment costs stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cardiac Ablation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is dominating the market over the forecast period owing to the presence of major pharmaceutical and medical equipment companies, a rising number of clinical trials, and substantial investments in the development of cardiac ablators in this region. Asia-Pacific is the fastest growing region over the forecast period owing to factors such as increased patient awareness of diseases, a growing geriatric population, and the rapid adoption of ablation treatment for cardiovascular diseases in the region.

Major market player included in this report are:

• Medtronic Plc
• St. Jude Medical, Inc.
• Stryker Corporation
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Cardio Focus Inc.
• Biosense Webster Inc.
• CONMED Corporation
• Atricure, Inc.
• Olympus Corporation

Recent Developments in the Market:

• In August 2022, Medtronic acquired Affera, Inc., with the main objective of strengthening its cardiac ablation portfolio. The acquisition involved integrating a comprehensive cardiac mapping and navigation platform, which effectively merged unique diagnostic capabilities with focused pulsed field and radiofrequency ablation solutions. This integration signifies a significant advancement in Medtronic's cardiac ablation offerings.
• In September 2022, Biosense Webster, Inc., a division of Johnson & Johnson MedTech, launched the OCTARAY Mapping Catheter featuring TRUEref Technology, leveraging the capabilities of the CARTO 3 Version 7 System. Tailored for precise mapping of cardiac arrhythmias, including atrial fibrillation (AFib), this advanced catheter enhances diagnostic capabilities in the field of cardiology.

Global Cardiac Ablation Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Technology, Application, End-Use, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Cyroablation Devices
• Radiofrequency Ablators
• Electrical ablators
• Ultrasound ablators
• Others

By Technology:

• Cyroablation
• Radiofrequency (RF) Ablation
• Electrical Ablation
• Ultrasound Ablation
• Microwave Ablation

By Application:

• Cardiac Rhythm Management
• Open Surgery
• Others

By End-Use:

• Hospitals
• Cardiac Centers
• Ambulatory surgical centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Cardiac Ablation Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Cardiac Ablation Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Cardiac Ablation Market, by Technology, 2020-2030 (USD Billion)
  • 1.2.4. Cardiac Ablation Market, by Application, 2020-2030 (USD Billion)
  • 1.2.5. Cardiac Ablation Market, by End-Use, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cardiac Ablation Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cardiac Ablation Market Dynamics

• 3.1. Cardiac Ablation Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing Aging Population
    • 3.1.1.2. Increasing prevalence of cardiovascular diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent regulations
    • 3.1.2.2. High investment cost
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Technological advancements in cardiac ablation
    • 3.1.3.2. Introduction of advanced robotic technologies

Chapter 4. Global Cardiac Ablation Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiac Ablation Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Cardiac Ablation Market by Product , Performance - Potential Analysis
• 5.3. Global Cardiac Ablation Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Cardiac Ablation Market, Sub Segment Analysis
  • 5.4.1. Cyroablation Devices
  • 5.4.2. Radiofrequency Ablators
• 5.5. Electrical ablators
• 5.6. Ultrasound ablators
• 5.7. Others

Chapter 6. Global Cardiac Ablation Market, by Technology

• 6.1. Market Snapshot
• 6.2. Global Cardiac Ablation Market by Technology , Performance - Potential Analysis
• 6.3. Global Cardiac Ablation Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 6.4. Cardiac Ablation Market, Sub Segment Analysis
  • 6.4.1. Cyroablation
  • 6.4.2. Radiofrequency (RF) Ablation
  • 6.4.3. Electrical Ablation
  • 6.4.4. Ultrasound Ablation
  • 6.4.5. Microwave Ablation

Chapter 7. Global Cardiac Ablation Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Cardiac Ablation Market by Application , Performance - Potential Analysis
• 7.3. Global Cardiac Ablation Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 7.4. Cardiac Ablation Market, Sub Segment Analysis
  • 7.4.1. Cardiac Rhythm Management
  • 7.4.2. Open Surgery
  • 7.4.3. Others

Chapter 8. Global Cardiac Ablation Market, by End-Use

• 8.1. Market Snapshot
• 8.2. Global Cardiac Ablation Market by End-Use , Performance - Potential Analysis
• 8.3. Global Cardiac Ablation Market Estimates & Forecasts by End-Use 2020-2030 (USD Billion)
• 8.4. Cardiac Ablation Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Cardiac Centers
  • 8.4.3. Ambulatory surgical centers
  • 8.4.4. Others

Chapter 9. Global Cardiac Ablation Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Cardiac Ablation Market, Regional Market Snapshot
• 9.4. North America Cardiac Ablation Market
  • 9.4.1. U.S. Cardiac Ablation Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Technology breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End-Use breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Cardiac Ablation Market
• 9.5. Europe Cardiac Ablation Market Snapshot
  • 9.5.1. U.K. Cardiac Ablation Market
  • 9.5.2. Germany Cardiac Ablation Market
  • 9.5.3. France Cardiac Ablation Market
  • 9.5.4. Spain Cardiac Ablation Market
  • 9.5.5. Italy Cardiac Ablation Market
  • 9.5.6. Rest of Europe Cardiac Ablation Market
• 9.6. Asia-Pacific Cardiac Ablation Market Snapshot
  • 9.6.1. China Cardiac Ablation Market
  • 9.6.2. India Cardiac Ablation Market
  • 9.6.3. Japan Cardiac Ablation Market
  • 9.6.4. Australia Cardiac Ablation Market
  • 9.6.5. South Korea Cardiac Ablation Market
  • 9.6.6. Rest of Asia Pacific Cardiac Ablation Market
• 9.7. Latin America Cardiac Ablation Market Snapshot
  • 9.7.1. Brazil Cardiac Ablation Market
  • 9.7.2. Mexico Cardiac Ablation Market
• 9.8. Middle East & Africa Cardiac Ablation Market
  • 9.8.1. Saudi Arabia Cardiac Ablation Market
  • 9.8.2. South Africa Cardiac Ablation Market
  • 9.8.3. Rest of Middle East & Africa Cardiac Ablation Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Medtronic Plc
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. St. Jude Medical, Inc.
  • 10.3.3. Stryker Corporation,
  • 10.3.4. MicroPort Scientific Corporation
  • 10.3.5. Boston Scientific Corporation
  • 10.3.6. Cardio Focus Inc.
  • 10.3.7. Biosense Webster Inc.
  • 10.3.8. CONMED Corporation
  • 10.3.9. Atricure, Inc.
  • 10.3.10. Olympus Corporation

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption